ALPS Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-52,273
| Closed | -$895K | – | 1025 |
|
2023
Q1 | $895K | Sell |
52,273
-1,096
| -2% | -$18.8K | 0.01% | 493 |
|
2022
Q4 | $1.04M | Buy |
53,369
+17,339
| +48% | +$339K | 0.01% | 472 |
|
2022
Q3 | $575K | Sell |
36,030
-3,024
| -8% | -$48.3K | 0.01% | 570 |
|
2022
Q2 | $537K | Sell |
39,054
-27,240
| -41% | -$375K | 0.01% | 569 |
|
2022
Q1 | $1.05M | Sell |
66,294
-8,283
| -11% | -$131K | 0.01% | 307 |
|
2021
Q4 | $1.63M | Sell |
74,577
-3,393
| -4% | -$74.1K | 0.02% | 306 |
|
2021
Q3 | $2.33M | Sell |
77,970
-5,133
| -6% | -$153K | 0.02% | 267 |
|
2021
Q2 | $3.68M | Sell |
83,103
-28,669
| -26% | -$1.27M | 0.03% | 197 |
|
2021
Q1 | $4.96M | Buy |
111,772
+12,019
| +12% | +$533K | 0.05% | 176 |
|
2020
Q4 | $5.47M | Buy |
99,753
+29,372
| +42% | +$1.61M | 0.06% | 170 |
|
2020
Q3 | $1.61M | Sell |
70,381
-4,865
| -6% | -$111K | 0.02% | 261 |
|
2020
Q2 | $1.58M | Sell |
75,246
-23,245
| -24% | -$487K | 0.02% | 259 |
|
2020
Q1 | $1.37M | Sell |
98,491
-2,975
| -3% | -$41.5K | 0.02% | 240 |
|
2019
Q4 | $2.31M | Buy |
+101,466
| New | +$2.31M | 0.02% | 216 |
|
2018
Q4 | – | Sell |
-70,185
| Closed | -$1.73M | – | 927 |
|
2018
Q3 | $1.73M | Buy |
70,185
+13,008
| +23% | +$320K | 0.01% | 272 |
|
2018
Q2 | $1.12M | Buy |
+57,177
| New | +$1.12M | 0.01% | 314 |
|
2017
Q2 | – | Sell |
-5,792
| Closed | -$46K | – | 783 |
|
2017
Q1 | $46K | Sell |
5,792
-678
| -10% | -$5.39K | ﹤0.01% | 727 |
|
2016
Q4 | $158K | Sell |
6,470
-2,113
| -25% | -$51.6K | ﹤0.01% | 702 |
|
2016
Q3 | $325K | Sell |
8,583
-697
| -8% | -$26.4K | ﹤0.01% | 640 |
|
2016
Q2 | $276K | Buy |
9,280
+1,855
| +25% | +$55.2K | ﹤0.01% | 586 |
|
2016
Q1 | $220K | Sell |
7,425
-1,273
| -15% | -$37.7K | ﹤0.01% | 600 |
|
2015
Q4 | $394K | Buy |
+8,698
| New | +$394K | ﹤0.01% | 603 |
|